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Abstract.  A  tight junction-enriched  membrane  frac- 
tion has been used as immunogen  to generate  a 
monoclonal  antiserum  specific for this intercellular 
junction.  Hybridomas were screened for their ability 
to both react on an  immunoblot and localize to the 
junctional  complex region on frozen sections of 
unfixed mouse liver.  A  stable hybridoma line has  been 
isolated that  secretes an antibody  (R26.4C) that local- 
izes in thin  section images of isolated mouse liver 
plasma membranes  to the points of membrane contact 
at the tight junction.  This antibody recognizes a  poly- 
peptide of ,x,225,000  D, detectable in whole liver 
homogenates  as well as in the tight junction-enriched 
membrane  fraction.  R26.4C localizes to the junctional 
complex region of a  number of other epithelia,  includ- 
ing colon,  kidney,  and testis,  and to arterial  en- 
dothelium,  as assayed by immunofluorescent  staining 
of cryostat sections of whole tissue.  This antibody also 
stains  the junctional  complex region  in confluent 
monolayers of the Madin-Darby canine kidney epithelial 
cell line.  Immtmoblot analysis of Madin-Darby  ca- 
nine kidney cells demonstrates  the presence of a poly- 
peptide similar in molecular weight to that detected in 
liver,  suggesting that this protein  is potentially  a ubiq- 
uitous component of all mammalian  tight junctions. 
The 225-kD tight junction-associated  polypeptide is 
termed  "ZO-lY 
PITHELIA are sheets of cells that stand at the interface 
of two biologically distinct compartments. These cell 
layers form a semipermeable boundary at this inter- 
face and act to regulate the transit of ions and molecules be- 
tween compartments. For epithelial cells to form a complete 
permeability  barrier,  they  must  generate  and  maintain  a 
gasket-like  seal to occlude the intercellular  route between 
compartments.  This sealing  function is carried out by the 
zonula  occludens,  or tight junction.  Much morphological 
and physiological evidence suggest that the tight junction is 
a highly dynamic intercellular junction that plays a critical 
role in normal epithelial cell structure and function.  How- 
ever, very little information  is available regarding  the bio- 
chemical  composition  and  molecular  dynamics  of  this 
structure. 
Questions have been raised about whether the branching 
and anastomosing fibrils visible in freeze-fracture images of 
the tight junction are composed of protein or lipid (24, 34, 
38, 43). It has been demonstrated that protein synthesis in- 
hibitors block the development of normal transepithelial re- 
sistance, a parameter determined largely by the tight junc- 
tion,  in  freshly  plated  trypsinized  Madin-Darby  canine 
kidney  (MDCK) ~ cells (8,  16),  an  epithelial  cell line that 
1. Abbreviations used in this paper: DOC, sodium deoxycholate;  DOC-JR, 
DOC-insoluble junctional ribbons; DTT, dithiothreitol; FBS,  fetal bovine 
serum; MDCK,  Madin-Darby canine kidney;  TBS,  Tris-buffered  saline; 
TIU, trypsin inhibitor units. 
forms tight junctions  in vitro (9,  32).  Also,  tight junction 
structure is preserved after exposure to either Triton X-100 
or the anionic detergent sodium deoxycholate (DOC), treat- 
ments that would be expected to disrupt the normal lipidic 
environment  (40, 41). 
Very little direct information  is available regarding  pro- 
teins potentially involved in or associated with the tight junc- 
tion. Although a large body of literature concerns molecules 
involved in cell adhesion (see reference 11 for review), none 
of these have been localized to the tight junction. It has been 
shown that a monoclonal antibody directed against a uvo- 
morulin-like,  130-kD  polypeptide  can  disrupt  normal 
MDCK  cell polarity  and  the  tight junction,  and  shows a 
localized distribution  at  the junctional  complex  region  of 
some epithelial  cells upon immunofluorescent staining  (2, 
22).  Gumbiner  and  Simons  (17) have demonstrated  that a 
monoclonal  antibody  specific  for  a  molecule  similar  to 
uvomorulin can inhibit the formation of normal transepithe- 
lial resistance in MDCK monolayers. These authors localize 
this molecule to the lateral surface of this cell type, whereas 
uvomorulin has been localized to the zonula adherens in in- 
testinal  epithelial  cells using  immunoelectron  microscopy 
(6). Subcellular fractionation work from a number of labora- 
tories has extensively catalogued protein  markers  and en- 
zyme activities specific for either the sinusoidal,  lateral,  or 
canalicular  membrane  domains  in  the  hepatocyte  (1,  10, 
19-21, 29, 35-37). None of the markers, however, have been 
shown to be associated with the tight junction. 
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tion is as yet undetermined, although alpha-actinin and vin- 
culin have been localized to the cytoplasmic area near the 
tight junction by immunocytochemistry  (14). Implications of 
tight  junction-cytoskeletal  interactions  also  come  from 
studies which show that drugs that disrupt cytoskeletal ele- 
ments can also affect tight junction morphology and physiol- 
ogy (5, 30, 31). It has been demonstrated that contraction of 
isolated intestinal brush borders at the level  of the zonula 
adherens can result in alteration of tight junction structure 
(7, 25), leading to the hypothesis that this contraction may 
act in vivo to alter tight junction permeability. 
An alternative approach to studying the biochemical char- 
acteristics of the tight junction was established by the devel- 
opment of a  protocol for the isolation of tight junction- 
enriched membrane fractions from mouse hepatocytes (40). 
Through  selective subcellular  frationation and  extraction 
with the detergent DOC, a preparation is obtained that con- 
tains ribbon-like remnants of the junctional complex. Em- 
bedded  within  these  DOC-insoluble  junctional  ribbons 
(DOC-JR) are the structural elements characteristic of the 
tight junction. While the number of polypeptides present in 
the DOC-JR, as determined by SDS PAGE, is markedly re- 
duced relative to whole hepatocyte plasma membrane frac- 
tions, the gel profile remains complex. Attempts to further 
enrich subcellular preparations  for tight junction compo- 
nents have proven unsuccessful, largely because the only as- 
say for the tight junction up to this point has been morpho- 
logical. 
In light of these problems, we have attempted to obtain 
monoclonal antisera specifically reactive with elements of 
the tight junction. We report here that by using the DOC-JR 
as immunogen, a monoclonal antibody (R26.4C) has been 
generated which recognizes a polypeptide, of '~225,000 D, 
that is localized by immunoelectron microscopy to precisely 
the points of membrane contact of the hepatocyte tight junc- 
tion. In addition, R26.4C shows immunofluorescent staining 
of the tight junction region in frozen sections from a variety 
of mouse  and  rat  epithelia.  This  protein  has  also  been 
identified in the MDCK epithelial cell line. We have called 
the 225-kD protein "ZO-V to indicate that it is the first poly- 
peptide demonstrated to be exclusively associated with the 
tight junction. 
Materials and Methods 
All reagents were purchased from Sigma Chemical Co. (St. Louis, MO) un- 
less otherwise noted. 
Cell Fractionation 
Liver Tight Junction-enriched Fraction. The DOC-JR was isolated from 
mouse livers according to the protocol described by Stevenson and Good- 
enough (40) with the following modifications: Livers were homogenized in 
1  mM  NaHCO3,  pH  8.0, containing  2.5  Ixg/ml  leupeptin,  0.5  gg/rnl 
chymostatin, 0.5 Ixg/ml pepstatin, 30 Ixg/mi soybean trypsin inhibitor (1 lag 
inhibits 1.4 lxg trypsin), 0.1 trypsin inhibitor units (TIU)/ml aprotinin, and 
0.2 mM dithiothreitol (DTT). The same ingredients were also added to the 
detergent extraction solution (10 mM imidazole, pH 8.0, 1 mM EGTA, 0.5 % 
DOC).  All other solutions contained 0.02  TIU/ml aprotinin and 0.2 mM 
DTT.  The purification of the canaliculus-enriched fraction was done with 
a  two-step (41%/sample-25%) sucrose gradient in 12x  35-ml tubes and 
spun 90  min at  83,000  g,v in two SW-28  rotors (Beckman Instruments, 
Inc., Spinco Div., Palo Alto, CA). The particular DOC-JR used for the ira- 
munization resulting in the production of R26.4C was made with 1 lag/ml 
leupeptin, 2 ~tg/ml antipain, 0.01 TIU/ml aprotinin, 10 gg/ml benzamidine, 
I gg/mi chymostatin, 1 I~g/ml pepstatin, 5 mM phenylmethylsulfonyl fluo- 
ride (Eastman Kodak Co., Rochester, NY) and no DTT. All subsequent so- 
lutions,  including the detergent extractions, contained 0.01 TIU/ml aprotinin. 
MDCK. To prepare a plasma membrane-enriched fraction from MDCK 
cells, four 25-cm  2 flasks (Coming Glass Works, Coming, NY) of conflu- 
ent cells were rinsed twice with PBS (10 mM phosphate, pH 7.4,  150 mM 
NaCI) and the cells removed by scraping with a  rubber policeman in 2 
mi/flask buffer 11 (10 mM imidazole, pH 7.4, 4 mM EDTA, 1 mM EGTA, 
0.2 mM phenylmethylsulfonyl  fluoride, 0.1 TIU/ml aprotinin, 0.2 mM DTT, 
2.5 mg/ml leupepfin, 0.5 p.g/ml pepstatin, 30 I.tg/ml soybean trypsin inhibi- 
tor).  Cells were pooled and spun for 8 min at 400 g,~. All further steps 
were carried out at 4°C. The cells were resuspended in 7 ml buffer II and 
homogenized in a dounce homogenizer using five strokes with a tight fitting 
pestle. Cells, but not nuclei, were broken by this procedure and apices from 
several cells held together by their junctional complexes were visible by 
phase-contrast microscopy. The homogenate was spun for 10 min at 8,000 
g,~, and this low-speed supernatant was set aside.  The pellet was resus- 
pended in 10 mi buffer II and spun 10 min at 2,500 g,~. The supernatant 
was discarded and the pellet resuspended in 1 mi buffer II for analysis by 
SDS PAGE.  The original low-speed supernatant was spun 1 h at 100,000 
g~ in a  type 65 rotor (Beckman Instruments, Inc.) and both high-speed 
pellet and supernatant prepared for SDS PAGE analysis. 
SDS PAGE samples were also made from whole MDCK cell sheets. A 
confluent 25-cm  2 dish was rinsed three times with ice-cold PBS containing 
1 mM EGTA and 0.2 mM phenylmethylsulfonyl  fluoride (PBS'). Cells were 
removed from the dish by gentle scraping with a rubber policeman in 5 ml 
PBS', and pelleted by centrifugation for 5 rain at 400 g~.  The cell pellet 
(°o100 gl) was mixed with 100 ~tl of PBS' and resuspended by flicking the 
tube with a finger. Clumps of cells were clearly visible at this point. 80 gl 
of the cell suspension was slowly added to 20 I.tl of 10×  gel sample buffer 
(see below) that was sitting in a boiling water bath. Samples were boiled 
for an additional 2 min. 
Cell Culture 
The mouse myeloma cell line P3X63  Ag8U.1  (ATCC CRL 1597) was ob- 
tained from Drs. Victoria Lewis and Ira Mellman (Dept. of Cell Biology, 
Yale University School of Medicine). Cells were grown in either Dulbecco's 
modified Eagle's medium (DME) (cat. No. DM-326, KC Biological, Inc., 
Lenexa, KA) supplemented weekly with 2 mM glutamine, or RPMI-1640 
(KC Biological, Inc.) supplemented with 1 mM sodium pyruvau:,  plus 10% 
fetal bovine serum (FBS) (HyClone Laboratories, Logan, UT) and 100 U 
penicillin and 100 gg streptomycin/nil (Gibco Laboratories, Grand Island, 
NY).  Cell density was maintained at  1-6  x  105 cells/ml.  Hybridomas 
were grown in DME or RPMI-1640  supplemented with 20%  FBS,  10% 
NCTC-109  (KC  Biological,  Inc.)  and penicillin-streptomycin. Hypoxan- 
thine/aminopterin/thymidine  (HAT)  and  hypoxanthine/thymidine  (HT) 
from 50× lyophilized stocks (final concentrations 0.1 mM hypoxanthine, 4 
x  10  -4 mM aminopterin, 1.6 x  10  -2 mM thymidine) were added when ap- 
propriate.  MDCK  cells  were  grown  in  DME,  10%  FBS,  penicillin- 
streptomycin, and passaged weekly. All cells were maintained at 37°C in 
a humidified incubator with 95%  air/5% CO2. 
Monoclonal Antibodies 
Immunization.  10%  SDS  (BDH  Chemicals Lid.,  Poole,  England) was 
added to the DOC-JR suspension to a final concentration of 1% and boiled 
for 2 min. It was then combined with an equal volume of complete Freund's 
adjuvant (Gibco Laboratories) and emulsified. A female, 21-d-old CD rat 
(Charles River Breeding Laboratories, Inc., Wilmington, MA) was injected 
i.p. with 0.5 mg total protein for the primary immunization. After a 2-wk 
rest the rat was injected i.p. with 0.5 nag of  the identical SDS-denatured anti- 
gen emulsified with an equal volume of incomplete Freund's adjuvant. 1 wk 
later the animal was bled from the tail and a positive response to the im- 
munogen verified by dot assay (see below). The rat was again boosted i.p. 
4 d before fusion with 0.4 mg antigen without adjuvant. 
Fusion. Rat splenocytes were fused with the P3 myeloma cells according 
to the techniques of Fazekas de St. Groth and Scheidegger (12). 50% poly- 
ethylene glycol (PEG 4000,  Boehringer Mannheim Biochemicals, Indi- 
anapolis, IN) in RPMI-1640  containing 5% dimethylsulfoxide was used as 
the fusogen. The initial fusion products were plated in two 24-well plates 
(Linbro, Inc., Hamden, CT) in HAT medium and fed every 4 d. Cells were 
grown in media containing HAT during week 1 and media containing HT 
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onday 7. 
Screening. The original fusion master wells were first screened for posi- 
tive activity against SDS-denatured DOC-JR on a modified ELISA assay 
(42). Approximately 0.2 Itg antigen was dotted on small ('~9 mm  2) nitro- 
cellulose squares (0.2 ~tm, Schleicher & Schuell, Inc., Keene, NH). These 
squares were then blocked with PBS-BLOTTO (23,  5 % nonfat dry milk, 
Carnation Co., Los Angeles, CA) and sequentially incubated with culture 
well  supernatants,  peroxidase-conjugated rabbit anti-rat Ig  (Boehringer 
Mannheim, diluted 1:500 in PBS), and 0.05 % 3,3'diaminobenzidine, 0.01% 
H202 in PBS. A rat monoclonal antibody (graciously provided by Dr. Ira 
Mellman) dotted directly on the nitrocellulose served as a positive control. 
Culture wells that showed positive activity on the dot assay were then 
tested on frozen sections of unfixed mouse or rat liver. Small pieces of fresh 
liver from a young animal were rapidly frozen in isopentane with a mini- 
mum of handling and stored in liquid nitrogen. 5-10 gm frozen sections 
were cut and applied to gelatin-coated multispot microscope slides (Shan- 
don Southern Instruments Inc., Sewickley, PA), dipped in absolute acetone 
at -20"C for 2 rain, stained with the culture supernatant and fluorescein 
isothiocyanate-conjugated rabbit anti-rat Ig (Boehringer Mannheim, di- 
luted 1:200 in PBS), and viewed with a Zeiss light microscope (Carl Zeiss, 
Inc., Oberkochen, West Germany) equipped with epifluorescent illumina- 
tion and either 40x  or 63x  planapo objectives. 
Cloning and Propagation. Those wells that showed positive activity on 
both screens were immediately expanded and then plated out at cloned den- 
sity (0.8 cell/well) in a 96-well dish with round bottom wells into which a 
feeder layer of peritoneal macrophnges (12) had previously been plated. 
Clones were tested for antibody activity with the double screen as before. 
Positive wells were expanded and cloned a total of three times. 
Antibody-rich supernntants that were used in experiments were obtained 
from  hybridoma cultures  that  were  grown  to  a  density of ~1  ×  106 
cells/ml in standard culture media containing 20% FBS. For some experi- 
ments the hybridomas were grown to a density of 6--10 ×  lO  s cells/mi in 
standard culture media, centrifuged 8 min at 400 g~, and resuspeoded at 
the same density in RPMI-1640 containing 1% Nutridoma-SP (Boehringer 
Mannheim) and no FBS. After 24-48 h the supernatant was harvested by 
spinning first at 400 g,v for 8 rain to remove whole cells and then 15 rain 
at  21,000  ga,  to  remove any  other debris.  All  supernatants  were made 
0.02 % in sodium azide to prevent bacterial growth. 
Supernatants from cultures containing only the parent myeloma line, cul- 
ture media alone, culture media containing nonspecific rat IgG (100 Ixgtmi), 
or an anti-gap junction rat monoclonal antiserum (R5.21C)  were used as 
negative controls. 
Immunohistochemistry 
Light Microscopy. Frozen sections of various unfixed mouse or rat tissues 
were prepared for immunofluorescence  as described above for liver. In some 
cases the secondary fluorescein isothiocyanate-conjugated rabbit anti-rat 
antibody was adsorbed before use with mouse liver plasma membranes from 
the canaliculus-enriched fraction  (non-detergent treated):  This involved 
mixing undiluted secondary antibody solution with an equal volume of the 
canaliculus-enriched membrane pellet, incubated on ice for 1 h, and spun 
for 15 min at 15,000 g~. The supernatant was again mixed with an equal 
volume of  fresh membrane pellet, and incubated and spun as before. MDCK 
cells to be used for immunofluorescent staining were grown on sterile cover- 
slips and rinsed with PBS before dipping in acetone and staining. After 
staining, all samples were mounted with PBS/60% glycerol, 0.4% n-propyl 
gallate. Photographs were taken on Tri-X film (Kodak) and developed with 
D-76. 
Electron Microscopy. Canaliculus-enriched mouse bepatocyte plasma 
membranes were obtained from a 41%/25%  sucrose step gradient as de- 
scribed above. These membranes were washed free of sucrose by centrifu- 
gation in Tris-buffered saline (TBS;  10 mM Tris, pH 8.0, 150 mM NaCI). 
Membrane pellets were resuspended by trituration in undiluted tissue cul- 
ture supernatam containing either R26.4C or R5.21, the anti-gap junction 
monoclonal antibody. After a 3-h incubation at room temperature, the mem- 
branes were washed three times by centrifugation at 10,000 g~ for 10 rain 
in TBS, the final pellet resuspended directly in undiluted, preadsorbed rab- 
bit anti-rat secondary antiserum coupled to 5-nm gold (GARa G-5EM, 
Janssen Life Sciences Products, Piscataway, N J). Preadsorption was carried 
out using mouse canalicular membranes as described for fluorescent sec- 
ondary antibody for 2 h at room temperature, then washed three times with 
TBS as above. The final pellets were fixed in 2.5% glutaraldehyde in 0.1 M 
sodium cacodylate, pH 7.4,  postfixed in aqueous 2 % OsO4,  stained with 
1% aqueous uranyl acetate, and embedded in Epon. Sections were stained 
with load citrate before viewing in a Siemens Elmiskop 101 (Siemens-Allis 
Inc., Cherry Hill, NJ). 
Biochemistry 
SDS PAGE (27) was performed using 5-16% gradient minigels (28). 7.5% 
regular sized slab gels were used for the anti-gap junction irnmunoblot. Gel 
sample buffer was made as a  10×  stock containing 12.5 mM Tris, pH 6.8, 
10% SDS, 20% 13-mercaptoethanol,  20% sucrose, 0.5% bromphenol blue. 
Immunoblots were run according to a modification of  the techniques of  Tow- 
bin et al. (42). Gels were electrophoretically transferred (Trans-Blot Cell, 
Bio-Rad Laboratories, Inc., Richmond, CA, or TE Series Transphor Elec- 
trophoresis Unit, Hoefer Scientific Instruments, San Francisco, CA) onto 
0.2 Itm pore nitrocellulose paper (Schleicher &  Schuell, Inc.) in 25 mM 
Tris, pH 7.0, 192 mM glycine, 0.1% SDS, 20% methanol at 40 V for 24 h. 
The nitrocellulose was rinsed with dH20,  stained for total protein with 
0.2%  ponceau S  in 3%  trichloroacetic acid,  destained with dH20,  and 
trimmed into appropriate lane groupings. Nonspecific protein binding was 
blocked with TBS/BLOI'TO. Hybridoma culture supernatant containing the 
primary antibody was used undiluted, and the secondary antibody and de- 
veloping solutions were as described above for the dot assay. TBS was used 
throughout. Molecular weight standards run on the same gels included hu- 
man erythroid spectrin (240 and 220 kD) and chicken brush borders con- 
taining myosin (200 kD), villin (95 kD), fimbrin (68 kD), and actin (42 kD). 
Photographs of  both gels and immunoblots were taken with Kodak Ektapan 
film (4162). Protein determinations we!e made according to the method of 
Hartree (18). 
Results 
Monoclonal Antibody Generation 
A rat-mouse fusion was performed and screened for the abil- 
ity to react with both the SDS-denatured ZO-enriched frac- 
tion DOC-JR and the junctional complex region on a frozen 
section of  unfixed liver. The  junctional complexes in this epi- 
thelial tissue are easily visualized in their obligatory position 
immediately adjacent to and on either side of the lumen of 
the bile canaliculus where they delineate the boundary be- 
tween the apical, or canalicular, and basolateral, or serosal, 
compartments. Of the initial 48 fusion master wells from rat 
26, 41 showed positive activity for both SDS-denatured anti- 
gen and the junctional complex region on frozen liver sec- 
tions. Several wells were immediately expanded and cloned 
and from these a single stable hybridoma line, R26.4C, has 
been obtained. The localization of R26.4C using indirect im- 
munofluorescence on a cryostat section of liver is shown in 
Fig.  1. Characteristic staining of the junctional complex re- 
gion is revealed with this technique, visible in cross-section 
as a distinct pair of  dots on either side of the bile canaliculus, 
and in longitudinal section as "railroad tracks; or two con- 
tinuous lines, running along the lateral hepatocyte surface, 
again straddling the bile canaliculus. Branching of the bile 
canaliculi is also frequently observed, visible as a triad of 
paired lines (inset, Fig.  1). No other hepatocyte membrane 
surface or  cytoplasmic  domain  was  stained  above back- 
ground levels with R26.4C. 
Ultrastructural Localization 
The immunofluorescent staining indicates that antibody ac- 
tivity is localized to the area of the junctional complex, but 
does not identify the specific reacting component. Standard 
approaches to this problem,  such as ultrathin  frozen sec- 
tions, are made difficult by the fact that R26.4C does not 
react  with  tissue  that  has  undergone  even mild  fixation. 
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liculus-enriched  fraction  were  used  to  immunolocalize 
R26.4C at the electron microscopic level according to the 
techniques of Paul and Goodenough (33). As seen in Fig. 2, 
a and b, this antibody specifically stains the cytoplasmic sur- 
face of  the tight  junction. Labeling is observed either directly 
over or immediately adjacent to the points of membrane con- 
tact characteristically visible in thin-section images of this 
junction.  No labeling is deW.~zted on nonjunetional mem- 
branes, or at zonulae adhaerentes, desmosomes, or gap junc- 
tions. Another rat-derived monoclonal antibody, specific for 
the gap junction 27-kD polypeptide, was used as a functional 
negative control. This antibody exclusively labels the cyto- 
plasmic surface of the gap junction and not the tight  junction 
or any other membrane or intercellular junction (Fig. 2 c). 
Tissue Cross-reactivity 
The potential presence of the R26.4C epitope in the junc- 
tional complexes from other epithelia was assessed by im- 
munofluorescent staining of cryostat sections of a variety of 
mouse and rat tissues. These results, demonstrating R26.4C 
staining in  the epithelia of colon,  kidney, and testes are 
shown in Fig. 3 and 4. In the colon, staining is observed in 
cross-section as bright spots at the apical-most aspect of the 
lateral surface of the absorptive epithelial cell (Fig. 3 a). In 
oblique or longitudinal section, belt-like or circumferential 
staining is seen around the apical pole of each cell (Fig. 3 
b). R26.4C antibody activity is also detected in the junctional 
complex region in cross-sections of kidney tubule epithelia 
and in the junctional regions between contiguous arterial en- 
dothelial cells (Fig. 4 a). Similar endothelial staining is ob- 
served in an arteriole in the tunica propria between adjacent 
seminiferous tubules of the mouse testis. Sertoli-Sertoli cell 
junctions are also brightly stained where they separate the 
basal and adlumenal testicular compartments (Fig. 4 b). 
To determine the presence of R26.4C activity in epithelia 
from a different species, confluent monolayers of the canine- 
derived  MDCK epithelial  cell  line  were  stained  for im- 
munofluorescence. Fig. 5 shows distinct antibody binding in 
these cells, visible as a network of staining surrounding each 
cell where it meets its neighbors. Optical sectioning reveals 
that this staining pattern is produced by a discreet band of 
fluorescence at the apical-lateral border of  these cells, rather 
than continuous staining of the entire lateral surface. 
Biochemistry 
Immunoblot analysis was performed to determine which of 
the polypeptides present in the DOC-JR fraction is recog- 
nized by the R26.4C antibody. When samples from sequen- 
tial steps in the DOC-JR isolation protocol are run on SDS 
PAGE, transferred to nitrocellulose, and reacted for R26.4C 
activity, clear staining of a polypeptide at ,,o225 kD is ob- 
served (Fig. 6 b). This protein migrates between the a  and 
13 subunits of  human red blood cell spectrin. Successive frac- 
tions from the isolation protocol show a definite enrichment 
for this protein, ZOA. No obvious enrichment of a polypep- 
tide  in  this  molecular  weight  range  is  detected  on  the 
Coomassie Blue-stained gel of the same fractions. Minor 
bands of lower molecular mass (150-200  kD) and a general 
smeared staining in the region above ZO-1 are also visible 
in the immunoblots of Doe-JR. The higher molecular mass 
smearing can be quantitatively removed by passing the gel 
sample through a 0.2 I~m filter before SDS PAGE (Fig. 6, c 
and d). To verify both the presence and molecular weight of 
the R26.4C  antigen in the starting material,  an undiluted 
sample  was  taken from the  initial liver homogenate and 
processed for R26.4C activity. Fig. 6, c and d shows definite 
staining of a similar size polypeptide, indicating that ZO-1 
can be detected in whole liver and that gross proteolysis is 
not occurring during the isolation protocol. The anti-gap 
junction rat monoclonal antiserum (R5.21C) reacts with a 27- 
kD polypeptide and its 47-kD aggregate present in the DOC- 
JR fraction (Fig. 6 e). 
ZO-1  was  also  detected  in  a  biochemical  analysis  of 
MDCK cells. Samples of either whole, intact epithelial cell 
sheets added directly to boiling SDS or a low-speed pellet 
fraction enriched for MDCK plasma membranes isolated in 
the presence of protease inhibitors was prepared and run on 
an immunoblot for R26.4C activity. In both cases a band co- 
migrating with ZO-1 from liver is stained (Fig. 7). No activ- 
ity was detected in either the high speed pellet or supernatant 
fractions from the MDCK plasma membrane isolation pro- 
tocol. 
Discussion 
We have identified a 225-kD polypeptide, ZO-1, present in 
membrane fractions of the hepatocyte, which is specifically 
associated with the tight junction. Immunoreactive forms of 
ZO-I are present in the junctional regions of other epithelial 
and endothelial cell types as well, suggesting that ZO-1 is a 
ubiquitous component of the mammalian tight junction. 
The principle evidence for the identification of ZO-1 as a 
tight  junction component is the ultrastructural localization of 
this protein in preparations of canaliculus-enriched plasma 
membrane fractions from liver (Fig. 2). The epitope recog- 
nized by R26.4C is localized to the cytoplasmic surface of 
the tight junction membrane, providing evidence for the ex- 
clusive localization of ZO-1 to the tight junction in these iso- 
lated membrane preparations.  However,  it is possible that 
some rearrangement or selective loss of ZO-1 from other 
membrane surfaces during isolation could have occurred. 
While this possibility must be examined by immunolocaliza- 
tion of ZO-1  intact hepatocytes, the discrete nature of the 
staining patterns seen both by light microscopy in intact tis- 
sue and electron microscopy argues against the artifactual as- 
sociation of ZO-1 with the tight junction during membrane 
isolation. 
The relationship of ZO-1 to the tight  junction fibrils visual- 
ized in freeze-fracture (13, 26, 39) and in negatively stained 
preparations (15, 40) cannot be discerned from these ultra- 
Figure L Immunofluorescent  localization of ZO-1 in frozen sections of rat liver. The monoclonal antibody R26.4C specifically stains the 
junctional complex region of the hepatocytes. In cross-section, a pair of dots on either side of the bile canaliculus is observed, while in 
longitudinal section a pair of  parallel lines running along the lateral cell surface is visible. Inset shows  numerous bile canaliculi in longitudi- 
nal section. At points where they branch, a triad of paired lines is displayed. Bar, 10 gm. 
Stevenson et al. Tight  Junction Polypeptide  759 The Journal of Cell Biology, Volume 103, 1986  760 Figure 3. Immunofluorescent localization of ZO-1 in frozen sections of mouse colon. As in the liver (Fig. 1), R26.4C staining is restricted 
to the junctional complex of the enterocyte. (a) A cross-section view of adjacent intestinal villi and a portion of the intestinal lumen (L). 
Staining appears as bright dots at the apical-most aspect of the lateral cell surface (arrows).  (b) An oblique section through an intestinal 
crypt showing continuous belt-like fluorescence around the apical cell borders  (arrow).  Bar, 5 ~tm. 
structural studies.  The secondary antiserum-labeling meth- 
od  used  to  visualize  the  monoclonal  antibody  R26.4C  is 
limited  in  resolution  by  the  size  of the  sandwiched  im- 
munoreagents.  The  gold particles  are observed to  cluster 
around  the  points  of membrane contact  characteristically 
seen in thin-section images of the tight junction. With these 
data, however, it can only be concluded that ZO-1 is posi- 
tioned close to the tight junction fibrils; no conclusions about 
the nature of the relationship of ZO-1  to the  fibrils or the 
properties of the fibrils themselves can be drawn. 
The results obtained from the immunofluorescent staining 
of various rat and mouse epithelial tissues and the canine cell 
line  MDCK with  R26.4C  strongly  suggest that  ZO-1  is a 
ubiquitous  element  of  the  tight  junction  in  mammalian 
epithelia.  Ultrastructural  localization  of ZO-1  will  be  re- 
quired to positively identify it as a tight junction component 
in these other cell types. Nevertheless, the presence of an 
R26.4C immunoreactive polypeptide in MDCK cells which 
co-migrates with mouse liver ZO-1, indicates that ZO-1 is a 
conserved protein which may play key roles in tight junction 
structure,  function, and/or assembly. 
Although the biochemical and functional characterization 
of ZO-1 must await future study, the results presented here 
do provide some clues regarding  its properties as  well as 
some directions  for  future  experiments.  The  immunoblot 
analysis of successive steps in the purification of  the DOC-JR 
membrane fraction (Fig. 6, a  and b) indicates that the 225- 
kD  polypeptide reactive with  R26.4C  is  significantly  en- 
riched by these methods. It is also clear from comparison of 
the immunoblot with the Coomassie Blue-stained gel that 
ZO-1 is a relatively minor component of the final DOC-JR 
fraction.  In  fact,  unambiguous  assignment  of  the  im- 
munoreactive 225-kD band to one of the several high mo- 
lecular weight bands detectable by protein staining has thus 
far not been possible. 
The observation that ZO-1 can be detected in the initial 
liver homogenate (Fig. 6,  c and d) as well as in whole cell 
homogenates of MDCK cells (Fig. 7) suggests that this poly- 
peptide does not arise de novo during membrane fraction- 
ation from a higher molecular weight precursor. Proteolysis 
is clearly a problem since numerous lower molecular weight 
polypeptides immunoreactive with R26.4C are observed in 
Figure 2. (a and b) Ultrastructural  localization of ZO-I. Thin-section electron micrographs of the canaliculus-enriched  plasma membrane 
fraction incubated with R26.4C and a colloidal gold-conjugated  rabbit anti-rat secondary antibody before fixation and embedment.  Gold 
particles  decorate the cytoplasmic surface of the tight junction  at the precise points of membrane contact.  No labeling is detectable on 
any other membrane surface, including adjacent nonjunctional membrane and a gap junction  (G  J) which has been obliquely sectioned. 
(c) Same as in a and b, but using the monoclonal antibody  (R5.21C) that reacts with the 27-kD gap junction  protein.  Label is confined 
to the cytoplasmic surface of the gap junctions.  No label is visible at the tight junction  (ZO). Bars,  100 nm. 
Stevenson et aL Tight  Junction Polypeptide  761 Figure 4. Immunofluorescent localization of ZO-1 in frozen sections of mouse kidney and testis. (a) Kidney. R26.4C staining is observed 
in the junctional complexes in profiles of tubules in the kidney cortex. The endothelial junctions of an arteriole (A) are also stained with 
this antibody. (b) Testis. Portions of two seminiferous tubules are shown separated by the tunica propria (TP) connective tissue layer. R26.4C 
antibody activity is localized in this tissue to the Sertoli-Sertoli cell junctions (arrows) of the seminiferous epithelium. The endothelial 
junctions of an arteriole (4) in the tunica propria are also stained. Bar,  10 tam. Figure 5. Immunofluorescent localization of ZO-I in monolayers of the MDCK epithelial cell line. (a) Immunofluorescence. R26.4C activity 
is seen as a network of staining discreetly localized to a thin band around the apical borders of the cells. (b) Phase-contrast image of the 
same field as in a.  Bar,  20  ltm. Figure 6.  Immunoblot analysis of ZO-1 in fractions from the isolation of the tight junction-enriched preparation (DOC-JR). Molecular 
mass standards on the left  are in kilodaltons. Lane S, human erythrocyte spectrin. (a) Coomassie Blue-stained SDS PAGE  of (1) initial whole 
liver homogenate, (2) washed membrane pellet before loading on the sucrose step gradient, (3) plasma membrane pellet collected from 
the sucrose gradient, (4) purified plasma membrane "canaliculus-enriched" fraction, (5) supernatant from the first DOC wash, (6) DOC- 
extracted "low speed pellet" enriched for collagen and insoluble detritus, (7) DOC-JR. Equivalent amounts of protein were loaded in each 
lane. Lane 6 appears to contain less protein, probably because collagen does not run into the gel. (b) Immunoblot of an identical gel as 
that shown in a without the spectrin standard, stained with R26.4C. Enrichment of the 225-kD ZO-I band is observed. (c) Coomassie 
Blue-stained SDS PAGE and (d) identical R26.4-stained immunoblot of (1) undiluted initial whole liver homogenate, (2) DOC-JR, and 
(3) DOC-JR gel sample that has been passed through a 0.2-~tm filter. (e) Immunoblot of a DOC-JR sample run on a 7.5 % SDS PAGE 
and incubated with the monoclonal antibody R5.21C. Staining is detected at the gap junction 27-kD protein, its aggregate at 47-kD, and 
proteolysis fragments. 
some of  the membrane fractions, including the final DOC-JR 
fraction (Fig. 6 b). These lower molecular weight bands are 
most likely proteolytic fragments of  the 225-kD protein since 
their relative intensity can be increased under conditions 
such as detergent extractions in the absence of protease in- 
hibitors where proteolysis can be expected to be occurring. 
Final resolution of this issue will require either peptide map 
comparisons of  the 225-kD proteins with these putative frag- 
ments or the generation of similar sized fragments by pro- 
teolysis of purified  ZO-1.  The  R26.4C  immunoblots also 
demonstrate the anomolous behavior of ZO-1  on SDS gels 
in membrane fractions that have been pretreated with DOC 
before solubilization in SDS.  In such samples, an apparent 
aggregation of ZO-1 is observed, resulting in the presence of 
an amorphous smear of immunoreactive material extending 
from the 225-kD band up to the top of the gel (Fig. 6, b and 
d, and 7 b). Much of this smear can be removed by filtration 
of the gel sample before electrophoresis, although this also 
results in substantial loss of  the 225-kD immunoreactive pro- 
tein. The stability and aggregation behavior of ZO-1  in the 
presence of certain detergents may pose problems if these 
reagents are required for its solubilization and purification. 
One striking feature of ZO-1 is its relatively large molecu- 
lar weight. Its apparent molecular weight is comparable to 
the subunit molecular weights of the various isoforms of the 
membrane skeletal protein, spectrin, present in both eryth- 
roid and nonerythroid tissues including the liver (for review 
see reference 3). Given this similarity in molecular weight 
and its membrane association, it is possible that ZO-1 might 
actually be a spectrin isoform. Two lines of evidence argue 
against this. First, the distribution of spectrin in the hepato- 
cyte has been determined by immunohistochemical staining 
with anti-fodrin,  the major isoform of spectrin present in 
mammalian, nonerythroid tissues (3). These studies indicate 
that unlike ZO-1,  fodrin is present on all membranes of the 
hepatocyte,  and  shows  no preferential  localization to  the 
junctional complex region (4). Second, R26.4C shows no re- 
activity with purified mouse or human erythroid spectrin 
subunits, purified from rat or mouse small intestine (data not 
shown). These results do not rule out the possibility that ZO- 
1 may be a novel tight junction-associated spectrin subunit. 
The first issue to be addressed in future characterizations 
of ZO-1 will be the determination of whether this protein is 
a  peripheral  or  integral  component of the  tight junction 
membrane. The ultrastructural studies reported here indicate 
that ZO-1 is found, at least in part, on the cytoplasmic sur- 
face of the junction. Results of preliminary studies to deter- 
mine conditions required for extraction of  ZO-1 from hepato- 
cyte membranes suggest that this protein may be peripherally 
associated, since it is partially extracted by both high salt and 
alkaline pH (Anderson, J. M., and B. R. Stevenson, unpub- 
lished observations).  However, given the  susceptibility of 
ZO-1  to proteolysis, it is possible that the release of ZO-1 
from the membrane could result from cleavage of a relatively 
small  membrane insertion sequence from one end of the 
polypeptide. 
The Jourllal  of Cell Biology,  Volume  103, 1986  764 Figure  7.  Immunoblot  analysis  of  ZO-1  in  MDCK  cells  using 
R26.4C.  (a)  Coomassie  Blue-stained  SDS  PAGE  of  (S)  human 
erythrocyte  spectrin  (subunits  at  240  and  220  kD),  (1)  whole 
MDCK  cell sheets rapidly solubilized in boiling SDS,  (2) MDCK 
plasma membrane-enriched fraction.  (b)  R26.4C  immunoblot of 
the whole cell (1) and membrane fraction (2) from MDCK,  as in 
a. A  liver-derived DOC-JR sample (JR) was included as a molecu- 
lar weight marker.  The whole cell homogenate was run on a  sepa- 
rate gel to ensure that no spill-over of the liver antigen occurred. 
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